|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002871,
umls-concept:C0021747,
umls-concept:C0030705,
umls-concept:C0035525,
umls-concept:C0083104,
umls-concept:C0087111,
umls-concept:C0205531,
umls-concept:C0226896,
umls-concept:C0442027,
umls-concept:C0524910,
umls-concept:C0752221,
umls-concept:C1521801,
umls-concept:C1527415
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2004-12-28
|
|
pubmed:abstractText |
Interferon plus ribavirin (IFN/Rib) therapy is currently standard treatment for chronic hepatitis C. Hemolytic anemia, however, is a serious side effect of this treatment, requiring reductions in or complete withdrawal of ribavirin.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0944-1174
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1202-4
|
|
pubmed:meshHeading |
pubmed-meshheading:15622486-Administration, Oral,
pubmed-meshheading:15622486-Anemia, Hemolytic,
pubmed-meshheading:15622486-Antiviral Agents,
pubmed-meshheading:15622486-Drug Therapy, Combination,
pubmed-meshheading:15622486-Drugs, Chinese Herbal,
pubmed-meshheading:15622486-Female,
pubmed-meshheading:15622486-Hepatitis C, Chronic,
pubmed-meshheading:15622486-Humans,
pubmed-meshheading:15622486-Interferons,
pubmed-meshheading:15622486-Male,
pubmed-meshheading:15622486-Medicine, Kampo,
pubmed-meshheading:15622486-Middle Aged,
pubmed-meshheading:15622486-Retrospective Studies,
pubmed-meshheading:15622486-Ribavirin
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Orally administered Kampo medicine, Juzen-taiho-to, ameliorates anemia during interferon plus ribavirin therapy in patients with chronic hepatitis C.
|
|
pubmed:affiliation |
Jiaikai Imamura Bun-in Hospital, Kagoshima, Japan.
|
|
pubmed:publicationType |
Journal Article
|
